Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical... Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2 Xavier De Deken and Martine Raymond * Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2W 1R7 ABSTRACT Candida albicans azole-resistant clinical isolates overexpressing the CDR1 and CDR2 genes (multidrug transporters) also overexpress the PDR16 gene (phosphatidylinositol transfer protein). We show here that the PDR16 promoter displays higher transcriptional activity following integration in an azole-resistant isolate than in the matched azole-susceptible one. Thus, the upregulation of PDR16 in the resistant strain results from a mutation acting in trans . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Antimicrobial Agents and Chemotherapy American Society For Microbiology

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2

Antimicrobial Agents and Chemotherapy , Volume 48 (7): 2700 – Jul 1, 2004

Abstract

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2 Xavier De Deken and Martine Raymond * Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2W 1R7 ABSTRACT Candida albicans azole-resistant clinical isolates overexpressing the CDR1 and CDR2 genes (multidrug transporters) also overexpress the PDR16 gene (phosphatidylinositol transfer protein). We show here that the PDR16 promoter displays higher transcriptional activity following integration in an azole-resistant isolate than in the matched azole-susceptible one. Thus, the upregulation of PDR16 in the resistant strain results from a mutation acting in trans .

Loading next page...
 
/lp/american-society-for-microbiology/constitutive-activation-of-the-pdr16-promoter-in-a-candida-albicans-w1jN2W0U03

References (12)

Publisher
American Society For Microbiology
Copyright
Copyright © 2004 by the American society for Microbiology.
ISSN
0066-4804
eISSN
1098-6596
DOI
10.1128/AAC.48.7.2700-2703.2004
pmid
15215129
Publisher site
See Article on Publisher Site

Abstract

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2 Xavier De Deken and Martine Raymond * Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2W 1R7 ABSTRACT Candida albicans azole-resistant clinical isolates overexpressing the CDR1 and CDR2 genes (multidrug transporters) also overexpress the PDR16 gene (phosphatidylinositol transfer protein). We show here that the PDR16 promoter displays higher transcriptional activity following integration in an azole-resistant isolate than in the matched azole-susceptible one. Thus, the upregulation of PDR16 in the resistant strain results from a mutation acting in trans .

Journal

Antimicrobial Agents and ChemotherapyAmerican Society For Microbiology

Published: Jul 1, 2004

There are no references for this article.